- Home
- NRSN vs RSF Comparison
NRSN vs RSF Comparison
Compare NRSN & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- RSF
- Stock Information
- Founded
- NRSN 2017
- RSF 2016
- Country
- NRSN Israel
- RSF United States
- Employees
- NRSN N/A
- RSF N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- RSF Investment Managers
- Sector
- NRSN Health Care
- RSF Finance
- Exchange
- NRSN Nasdaq
- RSF Nasdaq
- Market Cap
- NRSN 50.1M
- RSF 49.1M
- IPO Year
- NRSN 2021
- RSF N/A
- Fundamental
- Price
- NRSN $1.06
- RSF $14.83
- Analyst Decision
- NRSN Buy
- RSF
- Analyst Count
- NRSN 2
- RSF 0
- Target Price
- NRSN $14.00
- RSF N/A
- AVG Volume (30 Days)
- NRSN 353.2K
- RSF 11.8K
- Earning Date
- NRSN 09-29-2025
- RSF 01-01-0001
- Dividend Yield
- NRSN N/A
- RSF 10.61%
- EPS Growth
- NRSN N/A
- RSF N/A
- EPS
- NRSN N/A
- RSF N/A
- Revenue
- NRSN N/A
- RSF N/A
- Revenue This Year
- NRSN N/A
- RSF N/A
- Revenue Next Year
- NRSN N/A
- RSF N/A
- P/E Ratio
- NRSN N/A
- RSF N/A
- Revenue Growth
- NRSN N/A
- RSF N/A
- 52 Week Low
- NRSN $0.68
- RSF $14.81
- 52 Week High
- NRSN $2.60
- RSF $16.23
- Technical
- Relative Strength Index (RSI)
- NRSN 33.59
- RSF 65.90
- Support Level
- NRSN $1.05
- RSF $14.70
- Resistance Level
- NRSN $1.17
- RSF $14.90
- Average True Range (ATR)
- NRSN 0.12
- RSF 0.05
- MACD
- NRSN 0.01
- RSF 0.01
- Stochastic Oscillator
- NRSN 10.00
- RSF 72.43
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.